Munich, Bavaria, Germany
Piero is an experienced executive and leader with a demonstrated history of working across different executive level roles in the pharmaceutical industry and a proven, successful track-record - from commercial to operations. He has a strong entrepreneurial growth mindset, excellent business acumen, a broad scope & digital skillset and profound experiences in various environments from mature to emerging markets. As VP DACH and Managing Director he is actually responsible for Advanz Pharma’s presence in Germany, Austria & Switzerland and will lead its further ambitious growth together with his amazing team.
Heading the newly created Biosimilars, Hospital & Specialty Gx BU at Stada Germany / Stadapharm as part of its leadership team incl. Marketing & Sales responsibilty and full P&L ownership.
Heading the Biosimilars BU at Stada Germany / Stadapharm as part of its leadership team incl. Marketing & Sales responsibilty and full P&L ownership.
Successful transformation of the Oncology Business Unit. Marketing & Sales responsibilty and full P&L ownership.
Heading Commercial Operations (Marketing & Sales incl. full P&L responsibility + related Operations) of the Hospital, Onco Injectables and Strategic Account Management Specialty Care units at Sandoz Germany (consisting of HEXAL AG and 1 A Pharma). The portfolio in scope consists of a broad Generics portfolio including eight Biosimilars. Company Officer with Statuatory Authority ("Prokurist")
Heading the Area Supply Chain Management Commercial Operations at Sandoz Germany (HEXAL AG, 1 A Pharma) & Member of the Sandoz Executive Committee for Germany ("Mitglied der Geschäftsleitung"), Company Officer with Statuatory Authority ("Prokurist").
As Head of Product Supply Europe I was in charge of Pan-European Supply Chain Planning, the S&OP Process, the European Distribution Network, Inventory Levels and their optimization, External Supply & CMO Management, Supply Chain Performance Management, and Supply Chain Risk Management. Additionally I had been managing Pan-European strategic Supply Chain Projects, had been the workstream lead "Supply Chain & Manufacturing" for the launch of Edoxaban (a NOAC) and was member of the European Management Forum.